Article · 28 Jun 2025
Research articlePublished 2014
Telmisartan is More Effective than Taurine in Protecting High Fat Diet Induced Obesity in Rats from Hypertension, Some Metabolic, Oxidative Stress and Vascular Complications
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Obesity, insulin resistance, hypertension and fatty liver, are key risk factors for vascular complications. So, this study aimed to compare between telmisartan and taurine supplementation on systolic blood pressure (SBP) in addition to some metabolic disturbances and some vascular complications in an animal model for obesity. Methods: Sixty male Wistar rats were randomly divided into six groups (n=10) for 8 weeks three groups of them received standard diet with either vehicle or taurine (3% w/v in drinking water) or telmisartan (5 mg/kg, oral) while the other three groups received high fat diet with either vehicle or taurine or telmisartan. Results: The high fat diet group had greater body weight and higher SBP as compared to control rats. Increased plasma glucose, lipid profile (except HDL), insulin, insulin resistance, MDA, and ADMA but decreased HDL, PON-1 and DDAH were also observed. Telmisartan or taurine administration resulted in decreased SBP, plasma glucose, lipid profile, insulin, insulin resistance, MDA, and ADMA but increased both plasma HDL level and PON-1activity, in addition to kidney DDAH enzyme activity with more significant effect of telmisartan than taurine. Taken together, these results support the more beneficial effect of telmisartan than taurinein obese rats by improving SBP, in addition to ameliorating hyperglycemia , dyslipidemia,( metabolic disturbances) and decreasing plasma ADMA but increasing kidney DDAH enzyme activities (vascular complications) at least in part, by improving insulin sensitivity and decreasing oxidative stress, suggesting the possible use of telmisartan as a protective strategy against vascular complications related to obesity.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cardiovascular Pharmacology: Open Access.
Article · 28 Jun 2025
Beta Blockers and Their Expanding Role in Cardiovascular Disease
Article · 28 Jun 2025
Emerging Role of PCSK9 Inhibitors in Lipid Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- SubjectCardiology
- BylineArticles whose byline prints “Maha Mohamed El Batsh”
- BylineArticles whose byline prints “Manal Mohamed El Batch”
